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Abstract
Many biomarkers from genetic, neuroimaging, and biological/biochemical measures have been recently developed
in order to make a shift toward the objective evaluation of psychiatric disorders. However, they have so far been
less successful in capturing dynamical changes or transitions in pathological states, such as those occurring during
the course of clinical treatments or pathogenic processes of disorders. A momentary biomarker is now required for
objective monitoring of such dynamical changes. The development of ecological momentary assessment (EMA)
allows the assessment of dynamical aspects of diurnal/daily clinical conditions and subjective symptoms. Furthermore,
a variety of validation studies on momentary symptoms assessed by EMA using behavioral/physiological/biochemical
measures have demonstrated the possibility of evaluating momentary symptoms from such external objective
measures. In this review, we introduce physical activity as a candidate biobehavioral biomarker for psychiatric
disorders. We also mention its potential as a momentary biomarker for depressive mood. Finally, we address the
continuous monitoring of the pathogenic processes and pathological states of depressive disorders based on
physical activity, as well as its application in pharmacological animal studies.
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Review
Seeking a momentary biomarker for psychiatric disorders
Diagnosis of psychiatric disorders largely relies on the
description of patients’ subjective symptoms (i.e., physical
symptoms and psychological states), causing difficulty in
objective evaluation of pathological states of patients.
Therefore, there is a recent tendency to incorporate “bio-
markers” into psychiatry to improve the current diagnostic
system (Singh and Rose 2009). A variety of physiological
or biological biomarkers, such as genetic (Lacerda-Pin-
heiro et al. 2014; Geaghan and Cairns 2015; Banigan et al.
2013), neuroimaging (Wolfers et al. 2015; Arnone et al.
2009; Vita et al. 2009; Wood et al. 2011; Schnack et al.
2014; Diler et al. 2013; Arribas et al. 2010), and biochem-
ical measures (Pagan et al. 2014; Yang et al. 2013), have
been identified through association studies with clinical
properties of disorders. Some of them have been able to
distinguish patients from healthy subjects (Banigan et al.
2013; Arribas et al. 2010; Pagan et al. 2014; Yang et al.
2013) or categorize patients according to their specific
psychiatric disorders (Schnack et al. 2014; Nakamura et al.
2007; Diler et al. 2013; Arribas et al. 2010; Banigan et al.
2013) with a certain level of the accuracy. However, they
have so far been less successful in capturing dynamical
changes in subjective symptoms or transitions of clinical
conditions, e.g., those following a clinical treatment (Boksa
2013), at sufficient time-resolutions.
The dynamical or “momentary” aspects of clinical con-
ditions and symptoms are considered important for the
diagnosis of the psychiatric disorders and also provide
more complete information about the disorders in ques-
tion. This is widely accepted, especially so in the field of
psychosomatic/behavioral medicine (Stone and Shiffman
1994; Conner and Barrett 2012; Trull and Ebner-Priemer
2009; Trull and Ebner-Priemer 2013; Shiffman et al. 2008;
Moskowitz and Young 2006), and thus methodological
developments to assess momentary information on symp-
toms, and in the analytical methods for such data (e.g.,
multilevel modeling), have been implemented over the last
two decades.
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Among these, ecological momentary assessment (EMA)
is a data collection technique capable of repeated real-
time assessments of behaviors, psychological states, and
physiological reactions in individuals’ daily life (Stone and
Shiffman 1994; Kim et al. 2013a). Because of its moment-
ary nature, EMA can enhance the ecological validity of
measurements and also avoid the retrospective recall ef-
fects which plague in traditional retrospective self-report
methods. With the increasing evidence on the usefulness
of this technique, EMA is now generally regarded as the
‘gold standard’ to assess the dynamical aspects of subject-
ive symptoms.
Many studies have examined the validity of EMA by
investigating covariate properties between momentary
self-reported symptoms and other external measures
(i.e., biomarkers) using various populations, one of these
being patients with psychiatric disorders. For example,
cardiovascular reactivity (Kamarck et al. 2005; Kamarck
et al. 1998; Smith et al. 2012; Grossman et al. 2008) and
cortisol-related reactivity (Robles et al. 2011; van Eck
et al. 1996; Smyth et al. 1998; Steptoe et al. 2007; Bitsika
et al. 2015) were reported to be associated with levels of
psychological stress, and changes in pulmonary func-
tions tested by a spirometer were associated with daily
positive/negative affect, as well as the symptom of short-
ness of breath in asthma patients. Health-related behav-
iors, such as eating (Lavender et al. 2013; Crosby et al.
2009), smoking (Chandra et al. 2011; Shiffman et al.
2007), and alcohol consumption (Muraven et al. 2005;
Jahng et al. 2011), exhibited associations with variation
in physical symptoms and psychological states, e.g., crav-
ing, positive/negative affect, and anxiety. Furthermore,
associations between physical activity measured by self-
report and daily fluctuations in psychological states have
been reported (Dunton et al. 2009; Wichers et al. 2012).
These studies provide strong evidence that various bio-
logical/physiological measures are associated with mo-
mentary symptoms, possibly in a concurrent fashion. In
addition, the existence of such external measures for
subjective symptoms indicates the possibility of the prac-
tical use of the biomarkers for monitoring momentary
symptoms in a continuous fashion simply by measuring
other physiological/biological data (i.e., without the need
for self-reports).
Behavioral abnormalities as an objective biomarker
Micro-fluctuations in physical activity contain rich infor-
mation on the dynamics of our bodily movements in
daily life. These data can be continuously obtained in an
unobtrusive manner through the use of a wrist-watch-
type activity monitor, referred to as an actigraph. The
detailed analysis of actigraph data has shown its poten-
tial as a psychobehavioral biomarker for psychiatric dis-
orders, and particularly for depressive disorders (Teicher
et al. 1995; Teicher et al. 1997; Burton et al. 2013; Indic
et al. 2012; Walther et al. 2012; Volkers et al. 2003; Berle
et al. 2010). For example, in major depressive disorder
(MDD), various types of behavioral alterations were ob-
served; decreased levels of physical activity during day-
time (Faurholt-Jepsen et al. 2012; St-Amand et al. 2013;
Teicher et al. 1995; Burton et al. 2013); sleep distur-
bances (Joffe et al. 2009; St-Amand et al. 2013); disrup-
tion of the circadian rhythm (Teicher et al. 1997;
Robillard et al. 2013; Teicher et al. 1995) as well as im-
provements over the course of clinical treatment (Baune
et al. 2007; Burton et al. 2013; Teicher et al. 1995).
Recent research has shown the existence of robust
statistical laws organizing daily life behaviors, specifically
how resting and active periods derived from physical
activity data are interwoven into daily life (Nakamura
et al. 2007). In addition, this research found a signifi-
cant alteration in the statistical law of resting period
durations in patients with MDD, as these patients ex-
hibited more intermittent behavioral patterns than
healthy subjects characterized by reduced mean activity
levels associated with occasional bursts of physical activity
counts (Nakamura et al. 2007; Nakamura et al. 2008). Fur-
thermore, alterations of intermittent properties of physical
activity have been reported in schizophrenia and bipolar
disorder (Sano et al. 2012; Nakamura et al. 2016). These
findings suggest that the intermittency of physical ac-
tivity is a useful measure for evaluating behavioral ab-
normalities associated with psychiatric disorders, and
that its characterization is likely to provide an objective
biomarker for these disorders. Interestingly, it has also
been shown that the statistical laws found in human be-
haviors are shared by mice, and similar alterations in
resting period durations to patients with MDD have
also been confirmed in mice with mutant circadian
clock genes (Nakamura et al. 2008).
Physical activity provides a momentary biomarker for
depressive mood
More recently, using multilevel modeling approaches
(Stone et al. 2007; Schwartz and Stone 1998), Kim et al.
probed the psychobehavioral correlates in temporal diur-
nal fluctuations in momentary depressive mood assessed
by EMA and behavioral dynamics (Kim et al. 2013b; Kim
et al. 2015). Their results showed that an increased inter-
mittency of physical activity appeared concurrently with
the worsening of depressive mood in healthy subjects
across a wide range of populations (adolescents, under-
graduates, and adult office workers) (Kim et al. 2013b), as
well as in patients with MDD (Kim et al. 2015) (Fig. 1-a).
Furthermore, the validity of the psychobehavioral corre-
lates across healthy subjects and patients with MDD were
confirmed, indicating that the same psychobehavioral cor-
relates are shared by both groups, though only the mean
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levels of depressive mood scores were significantly higher
in the MDD group (Kim et al. 2015).
Importance of physical activity and further challenges in
psychiatric research
Physical activity provides a behavioral biomarker for mo-
mentary depressive mood (Kim et al. 2015). Due to the
continuous nature of the measurement of physical activity,
this behavioral biomarker will enable assessment of diur-
nal changes of depressive mood with higher resolution
than the use of self-reports, contributing to the develop-
ment of “continuous” monitoring of pathological states in
psychiatric disorders (Fig. 1-b and -c). This continuous
monitoring has the potential to provide rich information
on dynamical aspects of momentary mood and largely
contribute to the development of early detection methods
of psychiatric disorders (Nakamura et al. 2016) as well as
the novel objective evaluation of their treatments.
One further application of the monitoring of symp-
toms might be in animal research (Fig. 1-c). Animal
studies have played a crucial role in psychiatric research
(Konopka and Roberts 2015; Cosgrove et al. 2015; Bolkan
et al. 2015); however, critical problems exist in the evalu-
ation of animal symptoms, such as “depressive mood.”
Diagnosis of humans mainly relies on verbal communica-
tion, making it impossible to diagnose animals using the
current human diagnostic system. Therefore, animal symp-
toms are often evaluated based on behavioral assessments
which can be impractical to directly apply to humans
(Nestler and Hyman 2010). The probing depressive mood
Fig. 1 A momentary biomarker for depressive mood. a The temporal associations of depressive mood and local statistics of physical activity.
Estimated values of the univariate multilevel model coefficient for the associations are shown in a colored matrix form consisting of 25 rows
(different location) and 12 columns (different size) in patients with MDD (n = 14). Each grid cell indicates specific location and size of a time frame
used for calculating the local statistics of physical activity surrounding each EMA recording of depressive mood. A color in each cell represents
the value of the model coefficient (γ10) of the predictors: local mean (left matrix) or skewness (right one) of physical activity which evaluate
lower/higher mean activity levels and asymmetry of a distribution, respectively (i.e., intermittency of physical activity). The false discovery rate with
the q value of .05 was used as the multiple comparison adjustment. Only the significant cases were shown by colors. Note that the univariate
model used for the analysis is as follows; Depressvie mood scoreij = γ00 + γ10 (Local statistics of locomotor activityij) + ζ0i + εij [see (Kim et al. 2013b)
for details]. b A estimation of momentary depressive mood from physical activity in a patient with MDD [modified from (Kim et al. 2015)]. The
parameters of the best-fitting multilevel model describing the temporal associations of depressive mood and local statistics of physical activity
were optimized individually using data collected at one week in the early part of the measurement. Subsequently, the momentary depressive
scores in another week in the later part of the measurement were estimated using personalized parameters and local statistics of physical activity.
In this patient, the correlation coefficient between self-reported (i.e., EMA recordings) and estimated depressive mood scores was considerably
high [r = 0.80 (p = 0.002)]. Note that the multilevel model we used for estimation is as follows: Depressive mood scoreij = γ00 + γ10 (Meanij) + γ20
(Skewnessij) + γ30 (Meanij × Skewnessij) + ζ0i + ζ1i (Meanij) + εij. c Challenges in continuous monitoring of depressive disorders and pharmacological
animal studies
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based on physical activity may partly solve the above prob-
lems and provide a new approach to bridge research about
human disorders with animal models.
In order to enhance the accuracy of mood estimation,
multidimensional approaches integrating a variety of bio-
markers from behavioral, clinical, mathematical, molecu-
lar, and imaging studies will be required (Singh and Rose
2009; Kennedy et al. 2012). Due to the complex nature of
psychiatric disorders, the presentation of symptoms,
process of development, and response to specific medica-
tions and treatments for each disease and even each indi-
vidual are highly diverse. While physical activity is a
robust measure, a single biomarker is not likely to be
enough to cover this diversity; the combination of physical
activity with other behavioral/physiological/biological bio-
markers is essential (Kennedy et al. 2012; McGorry et al.
2014). In addition, the development of mathematical
methodologies, especially the methods for repeated data
with individual variations [e.g., multilevel modeling (Stone
et al. 2007; Schwartz and Stone 1998) or machine learning
approaches (Bishop 1995)], may become necessary.
One further challenge would be a mathematical modeling
approach to psychiatric disorders. The recent development
of measurement technologies (e.g., the state-of-the-art
wearable devices) has enabled us to obtain high-quality,
multidimensional, and intensive longitudinal data (ILD)
(Walls and Schafer 2006). This ILD might open possible av-
enues to reconstruct/infer the dynamical systems under-
lying the transitions in observed physiological/biological
phenomena in psychiatric disorders (e.g., shifts in physical
activity data or momentary depressive mood scores). This
approach might also provide a novel framework for the
early detection of pathological transitions of disease states
(Nakamura et al. 2016).
Conclusion
Physical activity has potential as an objective biobehav-
ioral biomarker for psychiatric disorders. The presence
of psychobehavioral correlates between momentary de-
pressive mood and intermittent dynamics of physical ac-
tivity allow the continuous monitoring of pathogenic
processes and pathological states in depressive disorders.
It is possible that this approach will also be informative
in pharmacological animal studies, and future research
should explore these directions.
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